A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient Care.
作者信息
El-Galaly Tarec Christoffer, Gaidzik Verena I, Gaman Mihnea-Alexandru, Antic Darko, Okosun Jessica, Copland Mhairi, Sexl Veronika, Fielding Adele K, Doeswijk Robin, Parker Helen, Dreyling Martin, Döhner Konstanze, Almeida António Medina, Macintyre Elizabeth, Gribben John G, Grønbæk Kirsten
机构信息
Department of Hematology, Aalborg University Hospital, Aalborg, Denmark.
Department of Internal Medicine III, University Hospital of Ulm, Germany.
出版信息
Hemasphere. 2023 Feb 21;7(3):e842. doi: 10.1097/HS9.0000000000000842. eCollection 2023 Mar.
Abstract
摘要
相似文献
1
A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient Care.临床研究中缺乏多样性、公平性和包容性对患者护理有直接影响。
Hemasphere. 2023 Feb 21;7(3):e842. doi: 10.1097/HS9.0000000000000842. eCollection 2023 Mar.
2
Analysis of Transgender and Gender-Diverse Topics Within Diversity, Equity, and Inclusion Curricular Content in Pediatric Anesthesiology Fellowship Programs in the United States and Canada-A Prospective Survey.美国和加拿大儿科麻醉学 fellowship 项目中多元化、公平性和包容性课程内容内的跨性别和性别多样化主题分析——一项前瞻性调查
Paediatr Anaesth. 2025 Mar;35(3):207-214. doi: 10.1111/pan.15053. Epub 2024 Dec 7.
3
Development of an Equity, Diversity, and Inclusion Committee for a collaborative quality improvement network: Pediatric Cardiac Critical Care Consortium (PC) Equity, Diversity and Inclusion (EDI) Committee: white paper 2023.制定一个公平、多样性和包容性委员会，以支持一个协作的质量改进网络：儿科心脏危重病护理联盟（PC）公平、多样性和包容性（EDI）委员会：2023 年白皮书。
Cardiol Young. 2024 Mar;34(3):563-569. doi: 10.1017/S1047951123002950. Epub 2023 Aug 14.
4
Supervisor Authority and Its Impacts on Equity, Diversity, and Inclusion in National Collegiate Athletic Association Athletic Training Environments.监督权力及其对美国国家大学体育协会运动训练环境中的公平、多样性和包容性的影响。
J Athl Train. 2025 May 1;60(5):389-399. doi: 10.4085/1062-6050-0137.24.
5
Conceptualizing, operationalizing, and utilizing equity, diversity, and inclusion in clinical trials: a scoping review.在临床试验中对公平、多样性和包容性进行概念化、实施和利用：一项范围综述
J Clin Epidemiol. 2025 Mar;179:111649. doi: 10.1016/j.jclinepi.2024.111649. Epub 2024 Dec 20.
6
The American Urogynecologic Society Action Plan on Diversity, Equity, and Inclusion: Developed by the Diversity, Equity, and Inclusion Task Force.美国妇科学会关于多元化、公平与包容的行动计划：由多元化、公平与包容特别工作组制定。
Female Pelvic Med Reconstr Surg. 2022 Mar 1;28(3):127-130. doi: 10.1097/SPV.0000000000001169.
7
Diversity, equity and inclusion in ophthalmology.眼科学中的多样性、公平性和包容性。
Curr Opin Ophthalmol. 2023 Sep 1;34(5):378-381. doi: 10.1097/ICU.0000000000000970. Epub 2023 May 3.
8
Diversity, equity, and inclusion within the Society for Pediatric Anesthesia: A mixed methods assessment.儿科麻醉学会中的多样性、公平性和包容性：混合方法评估。
Paediatr Anaesth. 2023 Jun;33(6):435-445. doi: 10.1111/pan.14642. Epub 2023 Feb 7.
9
An Equity, Diversity, and Inclusion glossary for sociodemographic determinants of health within critical care medicine.重症医学中社会人口决定健康因素的公平、多样性和包容性术语表。
Can J Anaesth. 2024 Sep;71(9):1209-1218. doi: 10.1007/s12630-024-02824-z. Epub 2024 Sep 6.
10
Glossary of terms and concepts relating to diversity, equity, and inclusion to reflect on, debate, and raise awareness of: A report from the Society for Vascular Surgery Diversity, Equity, and Inclusion Committee.与多样性、公平性和包容性相关的术语和概念词汇表，旨在反思、辩论和提高认识：来自血管外科学会多样性、公平性和包容性委员会的报告。
J Vasc Surg. 2021 Aug;74(2S):125S-131S. doi: 10.1016/j.jvs.2021.03.045.
引用本文的文献
1
From Dialogue to Action: Community Recommendations for Inclusive Research Participation Among Underrepresented Populations.从对话到行动：社区对弱势群体参与包容性研究的建议
Health Expect. 2025 Aug;28(4):e70348. doi: 10.1111/hex.70348.
2
Greater gulf coast regional translational workforce development: Assessment and action plan.大湾岸地区转化医学劳动力发展：评估与行动计划
J Clin Transl Sci. 2025 Feb 18;9(1):e62. doi: 10.1017/cts.2025.31. eCollection 2025.
3
Priorities and expectations of researchers, funders, patients and the public regarding equity in medical research and funding: results from the PERSPECT qualitative study.研究人员、资助者、患者及公众对医学研究与资助公平性的优先事项和期望：PERSPECT定性研究结果
Int J Equity Health. 2025 Apr 2;24(1):90. doi: 10.1186/s12939-025-02458-7.
4
Increasing diversity in neuroimaging research: Participant-driven recommendations from a qualitative study of an under-represented sample.增加神经影像学研究的多样性：一项代表性不足样本的定性研究中参与者驱动的建议。
Dev Cogn Neurosci. 2024 Dec;70:101474. doi: 10.1016/j.dcn.2024.101474. Epub 2024 Nov 5.
5
Experiences, acceptability and feasibility of an isometric exercise intervention for stage 1 hypertension: embedded qualitative study in a randomised controlled feasibility trial.针对1期高血压的等长运动干预的经验、可接受性和可行性：随机对照可行性试验中的嵌入式定性研究
Pilot Feasibility Stud. 2024 Aug 26;10(1):113. doi: 10.1186/s40814-024-01539-8.
本文引用的文献
1
Participation of Lower and Upper Middle-Income Countries in Clinical Trials Led by High-Income Countries.中低收入国家参与高收入国家主导的临床试验。
JAMA Netw Open. 2022 Aug 1;5(8):e2227252. doi: 10.1001/jamanetworkopen.2022.27252.
2
Association of Remote Technology Use and Other Decentralization Tools With Patient Likelihood to Enroll in Cancer Clinical Trials.远程技术使用和其他分散工具与患者参与癌症临床试验的可能性的关联。
JAMA Netw Open. 2022 Jul 1;5(7):e2220053. doi: 10.1001/jamanetworkopen.2022.20053.
3
Quantifying geographical accessibility to cancer clinical trials in different income landscapes.量化不同收入水平地区癌症临床试验的地理可及性。
ESMO Open. 2022 Jun;7(3):100515. doi: 10.1016/j.esmoop.2022.100515. Epub 2022 Jun 21.
4
A national Danish proof of concept on feasibility and safety of home -based intensive chemotherapy in patients with acute myeloid leukemia.丹麦全国性概念验证研究：急性髓细胞白血病患者家庭为基础的强化化疗的可行性和安全性。
Leuk Res. 2022 Jan;112:106756. doi: 10.1016/j.leukres.2021.106756. Epub 2021 Nov 22.
5
Clinical development times for innovative drugs.创新药物的临床开发时间。
Nat Rev Drug Discov. 2022 Nov;21(11):793-794. doi: 10.1038/d41573-021-00190-9.
6
Disparities in phase 1 cancer clinical trial enrollment.癌症临床试验入组中的差异。
Cancer. 2021 Dec 1;127(23):4464-4469. doi: 10.1002/cncr.33853. Epub 2021 Aug 11.
7
Evaluation of Drug Trials in High-, Middle-, and Low-Income Countries and Local Commercial Availability of Newly Approved Drugs.高、中、低收入国家药物试验评估和新批准药物的当地商业供应情况。
JAMA Netw Open. 2021 May 3;4(5):e217075. doi: 10.1001/jamanetworkopen.2021.7075.
8
Impact of Organ Function-Based Clinical Trial Eligibility Criteria in Patients With Diffuse Large B-Cell Lymphoma: Who Gets Left Behind?基于器官功能的临床试验入选标准对弥漫性大 B 细胞淋巴瘤患者的影响：谁被落下了？
J Clin Oncol. 2021 May 20;39(15):1641-1649. doi: 10.1200/JCO.20.01935. Epub 2021 Feb 2.
9
The reality of informed consent: empirical studies on patient comprehension-systematic review.知情同意的现实：患者理解的实证研究-系统评价。
Trials. 2021 Jan 14;22(1):57. doi: 10.1186/s13063-020-04969-w.
10
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia.阿扎胞苷和维奈托克治疗未经治急性髓系白血病。
N Engl J Med. 2020 Aug 13;383(7):617-629. doi: 10.1056/NEJMoa2012971.
Zotero 插件